Eduardo Rodríguez-Noriega
University of Guadalajara
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eduardo Rodríguez-Noriega.
International Journal of Infectious Diseases | 2010
Eduardo Rodríguez-Noriega; Carlos Seas; Manuel Guzman-Blanco; Carlos Mejía; Carlos Arturo Álvarez; Luis Bavestrello; Jeannete Zurita; Jaime Labarca; Carlos M. Luna; Mauro José Costa Salles; Eduardo Gotuzzo
OBJECTIVES Methicillin-resistant Staphylococcus aureus (MRSA) is a prominent nosocomial bacterial pathogen, associated with significant morbidity and mortality. The global incidence is increasing, and Latin America is no exception. This article reviews MRSA clonal distribution in Latin America and implications for clinical practice. DESIGN A PubMed literature search (1966-2008) identified 32 articles that characterized MRSA clones in Latin America. RESULTS Data from these articles show that since 1990, several epidemic MRSA clones have spread in Latin America. The multidrug-resistant Brazilian clone is widespread, especially in Brazil and Argentina, but more recently clones with susceptibility to a range of antibiotics have been detected in Brazil, whereas in Argentina, as in Chile, Colombia and Paraguay, the multidrug-resistant Cordobes/Chilean clone prevails. In Mexico, the New York/Japan clone is most frequent. Data were not available from every country and, despite the increasing prevalence of community MRSA infections, most were collected from tertiary care centers. CONCLUSIONS A variety of epidemic MRSA clones are circulating in Latin America, some of which harbor genes that encode multidrug resistance or enhanced pathogenicity. Continued collection and reporting of epidemiological data is crucial for effective prevention and treatment.
Journal of Clinical Microbiology | 2010
Rodrigo E. Mendes; Lalitagauri M. Deshpande; Eduardo Rodríguez-Noriega; James E. Ross; Ronald N. Jones; Rayo Morfin-Otero
An oxazolidinone resistance mechanism (Cfr) was recently described in human isolates of staphylococci ([18][1]). Cfr causes posttranscriptional methylation of the 23S rRNA (A2503), affecting drugs belonging to several antimicrobial classes ([10][2]). cfr -carrying isolates recovered from human
International Journal of Antimicrobial Agents | 2009
Manuel Guzman-Blanco; Carlos Mejía; Raul Isturiz; Carlos Arturo Álvarez; Luis Bavestrello; Eduardo Gotuzzo; Jaime Labarca; Carlos M. Luna; Eduardo Rodríguez-Noriega; Mauro José Costa Salles; Jeannete Zurita; Carlos Seas
Methicillin-resistant Staphylococcus aureus (MRSA) has become a serious threat to public health worldwide. Ongoing surveillance is essential to support infection control committees and clinicians in the prevention and treatment of infection. However, in Latin America, resources for monitoring the changing epidemiology of MRSA remain limited. In this article, we review the current situation of MRSA in Latin America in order to highlight the need for a more harmonised effort to improve its management. Literature in the PubMed and SciELO databases as well as the website of the Pan American Health Organization were searched for articles and information about the epidemiology of MRSA in Latin America. MRSA is already the leading cause of nosocomial infection in the Latin American region, and the number of reports of community-acquired MRSA infections is also rising. However, the extent of the problem is not fully understood, especially since data tend to come from large hospitals whereas much of the population is served by small community healthcare centres that do not have extensive facilities for performing microbiological surveillance. In conclusion, wider-reaching and co-ordinated programmes to provide regular MRSA surveillance reports are required across the Latin American region.
Antimicrobial Agents and Chemotherapy | 2008
U. Garza-Ramos; Rayo Morfin-Otero; H. S. Sader; R. N. Jones; E. Hernández; Eduardo Rodríguez-Noriega; A. Sanchez; B. Carrillo; S. Esparza-Ahumada; Jesus Silva-Sanchez
ABSTRACT During 2003, 40 carbapenem-resistant Pseudomonas aeruginosa clinical isolates collected in a Mexican tertiary-care hospital were screened for metallo-β-lactamase production. Thirteen isolates produced IMP-15, and 12 had a single pulsed-field gel electrophoresis pattern. The blaIMP-15 gene cassette was inserted in a plasmid-borne integron with a unique array of gene cassettes and was named In95.
Epidemiology and Infection | 2010
Elvira Garza-González; Rayo Morfin-Otero; Jorge Llaca-Díaz; Eduardo Rodríguez-Noriega
Coagulase-negative staphylococci (CNS) are increasingly recognized to cause clinically significant infections, with S. epidermidis often cited as the third most common cause of nosocomial sepsis. Among CNS, there is a high prevalence of methicillin resistance associated with staphylococcal cassette chromosome (SCCmec) elements. Although identical SCCmec types can exist in S. aureus and CNS, some novel classes of SCCmec may be unique to CNS. Differences in the accuracy of identification of CNS species and use of non-standardized methods for the detection of methicillin resistance have led to confusing data in the literature. In addition to the review of SCCmec in CNS, in this paper we report a 2-year surveillance of methicillin-resistant CNS in a tertiary-care hospital in Guadalajara, Mexico.
Archives of Medical Research | 2009
Alejandra Esteves-Jaramillo; Saad B. Omer; Esteban Gonzalez-Diaz; Daniel A. Salmon; Brooke Hixson; Francisco Navarro; Simon Kawa-Karasik; Paula M. Frew; Rayo Morfin-Otero; Eduardo Rodríguez-Noriega; Ylean Ramirez; Araceli Rosas; Edgar Acosta; Vianey Varela-Badillo; Carlos del Rio
BACKGROUND AND AIMS Further cases of novel influenza A (H1N1) outbreak are expected in the coming months. Vaccination has been proven to be essential to control a pandemic of influenza; therefore, considerable efforts and resources have been devoted to develop a vaccine against the influenza A (H1N1) virus. With the current availability of the vaccine, it will be important to immunize as many people as possible. However, previous data with seasonal influenza vaccines have shown that there are multiple barriers related to perceptions and attitudes of the population that influence vaccine use. The aim of the study was to evaluate the acceptance of a newly developed vaccine against pandemic (H1N1) 2009 influenza A among healthcare workers (HCW) in Mexico. METHODS We conducted a cross-sectional study among HCW in three hospitals in the two largest cities in Mexico-Mexico City and Guadalajara-between June and September 2009. RESULTS A total of 1097 HCW participated in the survey. Overall, 80% (n = 880) intended to accept the H1N1 pandemic vaccine and 71.6% (n = 786) reported they would recommend the vaccine to their patients. Doctors were more likely to accept and recommend the vaccine than nurses. HCWs who intend to be immunized will be more likely to do so if they know that the vaccine is safe and effective. CONCLUSIONS Knowledge of the willingness to accept the vaccine can be used to plan strategies that will effectively respond to the needs of the population studied, reducing the health and economic impact of novel influenza A (H1N1) virus.
Microbial Drug Resistance | 2009
Rayo Morfin-Otero; Eduardo Rodríguez-Noriega; Lalitagauri M. Deshpande; Helio S. Sader; Mariana Castanheira
Three VIM-2-producing Enterobacteriaceae (two Enterobacter cloacae and one Klebsiella oxytoca) isolates recovered from patients in a Mexican hospital were characterized during the SENTRY Antimicrobial Surveillance Program (2005-2007). These strains carried identical bla(VIM-2) integrons in a 450-kb plasmid. The interspecies dissemination of this bla(VIM-2)-harboring element emphasizes the potential for spread of genetic structures carrying metallo-beta-lactamases that could limit therapeutic options in this geographic region.
Journal of Antimicrobial Chemotherapy | 2013
Gloria M. González; Rogelio de J. Treviño-Rangel; José Prisco Palma-Nicolás; César Martínez; J. Gerardo González; Jacobo Ayala; Amílcar Caballero; Rayo Morfin-Otero; Eduardo Rodríguez-Noriega; Fernando Velarde; Elba P. Ascencio; Juan Carlos Tinoco; Jorge Vázquez; Manuel A. Cano; Nidia León-Sicairos; Rocío González; Joaquín Rincón; Miguel A. Elías; Alexandro Bonifaz
OBJECTIVES To establish the species distribution and in vitro susceptibilities of 358 bloodstream fungal isolates from paediatric patients in Mexico. METHODS Isolates were collected during a 2 year surveillance programme in 14 medical centres in 10 Mexican states. A molecular approach was used to determine the Candida parapsilosis species complex. In vitro susceptibility to amphotericin B, fluconazole, voriconazole, itraconazole, posaconazole, caspofungin, anidulafungin and micafungin was determined according to CLSI procedures. Species-specific clinical breakpoints for fluconazole, voriconazole and echinocandins were applied. RESULTS Candida spp. accounted for 98.33% of fungaemias, including 127 Candida albicans isolates, 127 C. parapsilosis complex isolates (121 C. parapsilosis sensu stricto, 4 Candida orthopsilosis and 2 Candida metapsilosis strains) and 72 Candida tropicalis isolates. C. albicans and C. parapsilosis complex were the species predominant in neonates (48 cases each; 41.02%). C. parapsilosis complex was also the predominant species in patients 1 month to <2 years of age (P = 0.007). In contrast, C. albicans was the most frequent species in patients aged 2 to <12 years (P = 0.003). Antifungal resistance was rare among the subset of isolates. Candida glabrata showed the highest resistance rate to amphotericin B (1/9 isolates), fluconazole (1/9 isolates) and itraconazole (2/9 isolates). CONCLUSIONS The species distribution differed with the age of the patients, with C. albicans and C. parapsilosis complex being the most commonly isolated species. C. glabrata showed the highest resistance rate to amphotericin B, fluconazole and itraconazole. This is the first study of fungaemia episodes in Mexican children.
BMC Research Notes | 2012
Rayo Morfin-Otero; Juan Carlos Tinoco-Favila; Helio S. Sader; Lorena Salcido-Gutierrez; Hector R. Perez-Gomez; Esteban Gonzalez-Diaz; Luis Petersen; Eduardo Rodríguez-Noriega
BackgroundHospital-acquired infections caused by multiresistant gram-negative bacteria are difficult to treat and cause high rates of morbidity and mortality. The analysis of antimicrobial resistance trends of gram-negative pathogens isolated from hospital-acquired infections is important for the development of antimicrobial stewardship programs. The information obtained from antimicrobial resistant programs from two hospitals from Mexico will be helpful in the selection of empiric therapy for hospital-acquired gram-negative infections.FindingsTwo thousand one hundred thirty two gram-negative bacteria collected between January 2005 and December 2010 from hospital-acquired infections occurring in two teaching hospitals in Mexico were evaluated. Escherichia coli was the most frequently isolated gram-negative bacteria, with >50% of strains resistant to ciprofloxacin and levofloxacin. Klebsiella spp. showed resistance rates similar to Escherichia coli for ceftazidime (33.1% vs 33.2%), but exhibited lower rates for levofloxacin (18.2% vs 56%). Of the samples collected for the third most common gram-negative bacteria, Pseudomonas aeruginosa, >12.8% were resistant to the carbapenems, imipenem and meropenem. The highest overall resistance was found in Acinetobacter spp. Enterobacter spp. showed high susceptibility to carbapenems.ConclusionsE. coli was the most common nosocomial gram-negative bacilli isolated in this study and was found to have the second-highest resistance to fluoroquinolones (>57.9%, after Acinetobacter spp. 81.2%). This finding represents a disturbing development in a common nosocomial and community pathogen.
Brazilian Journal of Infectious Diseases | 2010
Eduardo Rodríguez-Noriega; Carlos Seas
MRSA clones belonging to the Brazilian, Pediatric, Cordobes/Chilean and New York/Japan clonal complexes are widely distributed across Latin America, although their individual distribution patterns and resistance to antimicrobial drugs are constantly changing. Furthermore, clones with increased virulence are beginning to appear more frequently both in hospital and community settings, and there is evidence that virulence factors can be transferred between hospital- and community-associated clones through recombination. These changing patterns have significant implications for clinical practice in the region. Most importantly, clinicians need to be aware of the changing antimicrobial resistance profile of circulating MRSA clones in their region in order to choose the most appropriate empiric antimicrobial therapy. Thus, regional molecular epidemiology programs are required across the region to provide accurate identification and characterization of circulating MRSA clones.